ESPR

Esperion Therapeutics, Inc.NASDAQHealthcare

$2.61+0.00%ClosedMarket Cap: $542.6M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-13	Citizens	—	Market Outperform	—
2026-03-03	Needham	—	Buy	—
2025-09-19	HC Wainwright & Co.	—	Buy	—
2025-06-17	HC Wainwright & Co.	—	Buy	—
2025-05-07	Needham	—	Buy	—
2025-04-25	HC Wainwright & Co.	—	Buy	—
2025-04-17	Goldman Sachs	—	Neutral	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$0.05	$444.7M	3
Sun Dec 31	$0.34	$553.2M	4
Mon Dec 31	$1.17	$884.5M	2
Tue Dec 31	$1.67	$1.12B	2